Lightnews — Scholar-powered news

Daniel Reed

@daniel-reed.bsky.social

130 followers 290 following 1 posts

Postdoctoral Researcher at Lund University in the Experimental Oncology Laboratory. Passionate about all things intravital imaging and uncovering the mechanisms of the tumour microenvironment

Posts Media Videos Starter Packs

Reposted by Daniel Reed

Thomas R. Cox @trcox.matrixandmetastasis.com · Jun 3

New review paper written by Jess Chitty in the team just out in Trends in Cancer (@cp-trendscancer.bsky.social) (OpenAccess)
The extracellular matrix in cancer: from understanding to targeting
| → www.sciencedirect.com/science/arti... ← |

The extracellular matrix in cancer: from understanding to targeting

Significant advances in matrix biology research have enhanced our understanding of individual matrix components and extracellular matrix (ECM) signall…

www.sciencedirect.com

4 9

Reposted by Daniel Reed

MBSANZ @mbsanz.bsky.social · Mar 26

Congratulations to @mbsanz.bsky.social MCR Paper of the Year 2024 Recipients, Brooke Pereira & Shona Ritchie, (co-led by @tcox.bsky.social ), for their latest work looking at the role of Nidogen-2 in pancreatic cancer published in Science Advances!

www.science.org/doi/10.1126/...

Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response

Temporal mass spectrometry proteomics, advanced microscopy, and in vivo modeling reveal nidogen-2 as a cotarget in PDAC.

www.science.org

4 8

Daniel Reed @daniel-reed.bsky.social · Mar 14

Excited to kick off my Bluesky posting by sharing this work by the lab looking at the role of neuropeptideY in #pancreaticcancer metastasis. An amazing piece of work and so thrilled to see it finally out!

@garvaninstitute.bsky.social

www.science.org/doi/10.1126/...

Targeting the NPY/NPY1R signaling axis in mutant p53–dependent pancreatic cancer impairs metastasis

Targeting NPY1R reduces mutant p53–dependent pancreatic cancer metastasis.

www.science.org

1 6